Innospec Inc.

IOSP Basic Materials Specialty Chemicals

Innospec Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, down 3.65% from fiscal 2024.

Revenue
+7.17%
EPS
+146.7%
Free cash flow
−88.7%

Quarter to September 2026, against a year earlier

77.67 1.46 −1.85%
Market cap
$2.0B
P/E
13.9×
Fwd P/E
19.5×
Dividend yield
2.27%
F-score
7/9
Altman Z
4.75
Beneish M
−2.46
Dividend safety
79/100

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Older periods Dec '25 Mar '26 Jun '26 Sep '26
Revenue

+8 more quarters

455.60 453.20 491.40 473.60
Revenue Growth
(2.40%) 2.81% 11.76% 7.17%
Gross Profit
127.40 123.50 138.30 129.10
Operating Income
46.80 36.50 39.70 41.70
EBT
49.10 39.90 41.60 42.60
Income after Tax
46.20 30.80 31.20 31.60
Net Income Common
47.40 30.40 30.80 31.80
EPS (Diluted)
1.91 1.22 1.25 1.28
Shares (Diluted, Weighted)
24.99 24.84 24.71 24.74
Gross Margin
27.96% 27.25% 28.14% 27.26%
EBIT Margin
10.27% 8.05% 8.08% 8.80%
Net Profit Margin
10.40% 6.71% 6.27% 6.71%
EBITDA
37.10 46.40 49.70 —
EBIT
46.80 36.50 39.70 41.70

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 5 Nov 2026